Dr Reddy's launches generic acid reflux drug in US

Drug firm Dr Reddy's Laboratories has launched generic Omeprazole and Sodium bicarbonate capsules, used for treatment of acid reflux and ulcers, in the US market after receiving approval from the country's health regulator.
The company has launched the capsules in the strengths of 20mg/1100 mg and 40 mg/1100 mg after the approval from the United States Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a filing to the BSE.
The company's capsules are generic version of Santarus Inc's Zegerid capsules, it added.
"The Zegerid brand and generic had US sales of approximately USD 306.7 million MAT for the most recent twelve months ending in May 2016 according to IMS Health," Dr Reddy's Laboratories said.